BINTRAFUSP ALFA

UNII:	NW9K8C1JN3
Formula:
Preferred Substance Name:	BINTRAFUSP ALFA

1918149-01-5
8L9YQ2N6PA
ANTI-PD-L1/TGFBETARII FUSION PROTEIN MSB0011359C
BINTRAFUSP ALFA [INN]
BINTRAFUSP ALFA [JAN]
BINTRAFUSP ALFA [USAN]
BINTRAFUSP ALFA [WHO-DD]
IMMUNOGLOBULIN G1, ANTI-(HUMAN PROGRAMMED CELL DEATH 1 LIGAND PROTEIN)(HUMAN .GAMMA.1-CHAIN) FUSION PROTEIN WITH 2-137-TRANSFORMING GROWTH FACTOR .BETA. RECEPTOR (HUMAN GENE TGFBR2 ISOFORM 1), DISULFIDE WITH ANTI-(HUMAN PROGRAMMED CELL DEATH 1 LIGAND PROTEIN)(HUMAN .LAMBDA.-CHAIN), DIMER
IMMUNOTHERAPIC BIFUNCTIONAL FUSION PROTEIN COMPRISED OF A FULLY HUMAN IGG1 MONOCLONAL ANTIBODY (AVELUMAB) AGAINST HUMAN PROGRAMMED DEATH-LIGAND 1 (PD-L1) FUSED TO THE SOLUBLE EXTRACELLULAR DOMAIN OF TRANSFORMING GROWTH FACTOR-.BETA. (TGF-.BETA.) RECEPTOR II, WHICH ACTS AS A TGF-.BETA. TRAP
M7824
M-7824
MSB0011359C
MSB-0011359C

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BINTRAFUSP ALFA

Synonyms and Mappings

Resources